Addressing Cell and Gene Therapy Manufacturing Challenges with Digital Solutions

Download the Körber eBook at the Bottom of the Page



Phacilitate is part of the Clarion Events Group of companies (Clarion).  

We take your privacy seriously. We wish to use your information on the basis of our legitimate interests to keep in contact with you about relevant events, products and services which may be of interest to you.

We will only ever use the information we collect or receive about you in accordance with our Privacy Policy. If you prefer us not to contact you about relevant events, products and services that we believe you will be interested in, you can manage your preferences via a link we will send you, unsubscribe using the link in our emails or by emailing

*If I have provided a non-business domain email address (such as, but not limited to, gmail, hotmail, etc) I am doing so in the context of it being used for my business and not personal interactions with Clarion.

**View Korber's Privacy Policy


As manufacturing pipelines scale in line with increased demand for advanced therapies, there is further demand for digital solutions to support complex manufacturing process development.

In considering some of the top challenges facing cell and gene therapies manufacturers today, there are many opportunities for reducing the costs associated with manufacturing, while accelerating delivery timelines, all through improving processes and integrating digital solutions.

Through the content in this eBook, we will explore the impact the burgeoning era of Pharma 4.0 may have on the cell and gene therapy industry, while considering several options for digital disruption, including cloud-based and software as a service (SaaS) offerings.

This eBook features exclusive insights from key opinion leaders in the digitization space, including Martin Sternitzke, Kortney Gunther (both Senior Product Managers) and Dr. Judith Koliwer (Principal Consultant for Cell & Gene Therapy) from Körber Business Area Pharma, as well as Joe Maguire (Head of GMP Automation and Data) and Kawa Chiu, (Former Vice President of CMC, Supply Chain and GMP Systems) from Lyell Immunopharma.

In this eBook, you will find:

  1. Infographic: Today’s Top Challenges for Cell and Gene Therapy Manufacturing

  2. Case Study: Scaling Out Production with a Robust Digital Foundation

  3. Interview: Overcoming Challenges in Cell and Gene Therapy Manufacture with Digitization, Cloud and SaaS Solutions